CN1069037C - Method for preparing oral capsule for treating difficult and complicated fracture - Google Patents

Method for preparing oral capsule for treating difficult and complicated fracture Download PDF

Info

Publication number
CN1069037C
CN1069037C CN95111304A CN95111304A CN1069037C CN 1069037 C CN1069037 C CN 1069037C CN 95111304 A CN95111304 A CN 95111304A CN 95111304 A CN95111304 A CN 95111304A CN 1069037 C CN1069037 C CN 1069037C
Authority
CN
China
Prior art keywords
radix
fracture
capsule
root
difficult
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95111304A
Other languages
Chinese (zh)
Other versions
CN1127131A (en
Inventor
唐兴华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95111304A priority Critical patent/CN1069037C/en
Publication of CN1127131A publication Critical patent/CN1127131A/en
Application granted granted Critical
Publication of CN1069037C publication Critical patent/CN1069037C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a method for preparing oral capsule for treating difficult and complicated fracture, which is prepared from Chinese medicinal materials of prepared rhizome of rehmannia, dipsacus root, drynaria rhizome, root of red rooted saliva, safflower, notoginseng, Chinese angelica root, astragalus root and greater celandine through the steps of disintegrating, ethanol immersing, percolating, decompressing evaporating, drying, granulating, loading into capsules and packaging, wherein the capsule has definite curative effect on the pathological fracture of cancer bone metastasis, old separated fracture and nonunion after fracture of femoral neck of old age, which is not solved clinically in orthopaedics in our country, and has obvious curative rate up to 98%, cure rate up to 100% for fresh fracture, no functional disorder left, shortened half of treatment time and fills the gap in difficult and complicated fracture treatment in our country.

Description

The manufacture method of treatment difficult and complicated fracture oral capsule
The present invention relates to a kind of manufacture method for the treatment of the difficult and complicated fracture oral drugs.
The traditional therapy of fracture is outer Plastering, and last small splints fixation allows bone fracture place normal healing, generally needs 2-3 individual month.Because union of fracture is slow, the relative fixed time is long, causes dysfunction, brings life to the patient, the inconvenience of work.And some difficult and complicated fractures can not be cured for a long time, cause the patient maimed throughout one's life.
In view of the limitation of tradition fracture therapy, the objective of the invention is to excavate motherland's medical science precious deposits, outstanding Chinese medicine characteristic, develop and a kind ofly can remove the fracture patient misery, also can save numerous patients from maimed person's edge the new drug of the treatment difficult and complicated fracture of returning.
The manufacture method of treatment difficult and complicated fracture oral capsule provided by the invention is to select for use genuine Chinese crude drug Radix Rehmanniae Preparata, Radix Dipsaci, Rhizoma Drynariae, Radix Salviae Miltiorrhizae, Flos Carthami, Radix Notoginseng, Radix Angelicae Sinensis, the Radix Astragali, Herba Chelidonii, Ophisaurus manufacturing to form, by 100%, the shared percentage by weight of each Chinese medicine of distinguishing the flavor of is with patent medicine weight:
Radix Rehmanniae Preparata 7~14% Rhizoma Drynariae 8~18%
Herba Chelidonii 8~16% Ophisaurus 8~15%
Radix Notoginseng 7~13% Sanguis Draxonis 10~14%
Radix Angelicae Sinensis 7~10% Radix Salviae Miltiorrhizaes 10~13%
Radix Dipsaci 4~7% Flos Carthamis 5~9%
The Radix Astragali 8~11%
The production technology of this medicine is as follows:
One, levigation percolation:
Each flavor Chinese medicine is come out by the prescription weighing, be developed into coarse powder altogether, in the percolator of packing into, add the soak with ethanol 12 hours of 75% concentration, make solvent fully permeate diffusion,, be generally decompression recycling ethanol 2~3 times with the speed percolation of per minute 3~5ml.
Two, reduction vaporization:
To remove alcoholic acid medicinal liquid and place in the evaporation boiler, attemperation is made into the thick paste shape between 40~60 ℃.
Three, drying and granulating:
Thick paste is positioned in the drying baker oven dry, makes granule then.
Four, encapsulated:
With capsule racking machine on the drug particles, dress up capsule by standard, packing, the oral capsule produced of the inventive method.
Treatment difficult and complicated fracture oral capsule according to prescription provided by the invention and production technology manufacturing, to cancer bone metastasis pathologisch Bruch, old diastatic fracture, the still unsolved clinically difficult problem determined curative effect of China's orthopaedics at present such as disunion after the old fracture of femoral neck, and highly significant, most thousand routine case clinical verifications through 7 years, cure rate reaches 98%, the treatment of fresh fracture is shortened half than the conventional therapy time, cure rate reaches 100%, generally do not leave over dysfunction, have and treat fast, cure rate advantages of higher.Succeeding in developing of this medicine is the important breakthrough of treatment difficult and complicated fracture, filled up the China and the blank of clinical treatment difficult and complicated fracture in the world, is the orthopaedics new drug that a kind of utmost point has promotional value.
Provide embodiment below:
Example 1:
With Radix Rehmanniae Preparata 13g Rhizoma Drynariae 9g Herba Chelidonii 15g Flos Carthami 5g
Ophisaurus 15g Radix Notoginseng 7g Sanguis Draxonis 10g Radix Astragali 8g
Radix Angelicae Sinensis 9g Radix Salviae Miltiorrhizae 12g Radix Dipsaci 4g is ground into coarse powder altogether, in the percolator of packing into, adds 75% soak with ethanol 12 hours, makes solvent fully permeate diffusion, with the speed percolation of per minute 3~5ml 2~3 times, and decompression recycling ethanol.
Remove alcoholic acid medicinal liquid and insert in the evaporation boiler above-mentioned, temperature is controlled at 40~60 ℃, makes the thick paste shape.
Thick paste is positioned over oven dry (temperature is controlled at 40~60 ℃) in the drying baker, makes granule then.
With capsule racking machine on the drug particles, dress up capsule by standard, packing promptly gets and specially controls difficult and complicated fracture, oral capsule evident in efficacy.
Example 2:
With Radix Rehmanniae Preparata 10g Rhizoma Drynariae 12g Herba Chelidonii 12g
Ophisaurus 11g Radix Notoginseng 10g Sanguis Draxonis 10g
Radix Angelicae Sinensis 8g Radix Salviae Miltiorrhizae 10g Radix Dipsaci 5g
Flos Carthami 8g Radix Astragali 9g.Production technology such as example 1.
Example 3:
With Radix Rehmanniae Preparata 14g Rhizoma Drynariae 15g Herba Chelidonii 15g
Ophisaurus 15g Radix Notoginseng 12g Sanguis Draxonis 12g
Radix Angelicae Sinensis 10g Radix Salviae Miltiorrhizae 11g Radix Dipsaci 7g
Flos Carthami 9g Radix Astragali 11g.All the other operations are with example 1.

Claims (1)

1, the manufacture method of treatment difficult and complicated fracture oral capsule, it is characterized in that selecting for use genuine Chinese crude drug Radix Rehmanniae Preparata, Radix Dipsaci, Rhizoma Drynariae, Radix Salviae Miltiorrhizae, Flos Carthami, Radix Notoginseng, Radix Angelicae Sinensis, the Radix Astragali, Herba Chelidonii, process through science, by 100%, the shared percentage by weight of each Chinese medicine of distinguishing the flavor of is with patent medicine weight:
Radix Rehmanniae Preparata 7~14% Rhizoma Drynariae 8~18%
Herba Chelidonii 8~16% Ophisaurus 8~15%
Radix Notoginseng 7~13% Sanguis Draxonis 10~14%
Radix Angelicae Sinensis 7~10% Radix Salviae Miltiorrhizaes 10~13%
Radix Dipsaci 4~7% Flos Carthamis 5~9%
The Radix Astragali 8~11%
Production technology is as follows:
One, levigation percolation:
Each flavor Chinese medicine is come out by the prescription weighing, be ground into coarse powder altogether, in the percolator of packing into, add the soak with ethanol 12 hours of 75% concentration, make solvent fully permeate diffusion,, be generally decompression recycling ethanol 2~3 times with the speed percolation of per minute 3~5ml;
Two, reduction vaporization:
To remove alcoholic acid medicinal liquid and place in the evaporation boiler, attemperation is made into the thick paste shape between 40~60 ℃;
Three, drying and granulating:
Thick paste is positioned in the drying baker dries, make granule then;
Four, encapsulated:
With capsule racking machine on the drug particles, dress up capsule by standard, packing.
CN95111304A 1995-04-05 1995-04-05 Method for preparing oral capsule for treating difficult and complicated fracture Expired - Fee Related CN1069037C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95111304A CN1069037C (en) 1995-04-05 1995-04-05 Method for preparing oral capsule for treating difficult and complicated fracture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95111304A CN1069037C (en) 1995-04-05 1995-04-05 Method for preparing oral capsule for treating difficult and complicated fracture

Publications (2)

Publication Number Publication Date
CN1127131A CN1127131A (en) 1996-07-24
CN1069037C true CN1069037C (en) 2001-08-01

Family

ID=5078607

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95111304A Expired - Fee Related CN1069037C (en) 1995-04-05 1995-04-05 Method for preparing oral capsule for treating difficult and complicated fracture

Country Status (1)

Country Link
CN (1) CN1069037C (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071843A (en) * 1992-12-18 1993-05-12 柳海峰 The preparation method of " three-flower " bone-knitting powder
CN1084765A (en) * 1993-07-21 1994-04-06 陈俊如 Stasis-removing bone-setting medicine
CN1090196A (en) * 1993-10-30 1994-08-03 陈显志 Liquid for curing bone fracture
CN1098935A (en) * 1994-05-23 1995-02-22 柴开源 A kind of relaxing muscles and tendons to promote blood circulation Chinese medicine composition and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071843A (en) * 1992-12-18 1993-05-12 柳海峰 The preparation method of " three-flower " bone-knitting powder
CN1084765A (en) * 1993-07-21 1994-04-06 陈俊如 Stasis-removing bone-setting medicine
CN1090196A (en) * 1993-10-30 1994-08-03 陈显志 Liquid for curing bone fracture
CN1098935A (en) * 1994-05-23 1995-02-22 柴开源 A kind of relaxing muscles and tendons to promote blood circulation Chinese medicine composition and preparation method thereof

Also Published As

Publication number Publication date
CN1127131A (en) 1996-07-24

Similar Documents

Publication Publication Date Title
CN1057451C (en) Children coryza medicine and preparing method
CN102145128A (en) Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof
CN1027622C (en) A tonic and health protecting preparation
CN1118258A (en) Preparation of brain-care pill
CN1965951A (en) Blood tonic capsule having ass hide and method for preparing same
CN100512855C (en) Method for preparing medication of gastrodia tuber and tuber of multiflower knotweed
CN1069037C (en) Method for preparing oral capsule for treating difficult and complicated fracture
CN1404854A (en) Medicine for treating nosal inflammation
CN1712060A (en) Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease
CN1025774C (en) Special "shanhaidan" and its production method
CN103285128B (en) Traditional Chinese medicine for treating bronchial asthma and preparation method thereof
CN1261130C (en) Medicine for dispelling tinea
CN1194733C (en) Medicine for treating hyperthyroidism and its prepn
CN1060663C (en) Compound Tibet capillary artemisia patent medicine
CN1036503C (en) Medicine for treating systemic lupus erythematosus and producing method thereof
CN1164318C (en) Capsule for treating gynaecological inflammation
CN1163252C (en) Tianjian capsule and its preparing process
CN101693065A (en) Medicament for treating polymyalgia rheumatica and preparation method thereof
CN1238028C (en) Method for preparing capsule of six drugs containing rehmannine
CN101194940A (en) Anti-inflammation medicament for treating toothache and preparation method thereof
CN1943717A (en) A Chinese traditional medicinal composition for treatment of low blood pressure and its preparation method
CN1068217C (en) Traditional Chinese medicine for treating skin disease and veneral disease
CN1064844C (en) Chinese medicine
CN1175461A (en) Medicine composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof
CN1119116A (en) Medicine for curing angiocardiopathy and cerebrovascular diseases and preparing process thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee